Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12250-020-00327-x http://scihub22266oqcxt.onion/10.1007/s12250-020-00327-x 33394351!7779898!33394351     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Virol+Sin 2020 ; 35 (6): 713-724 Nephropedia Template TP {{tp|p=33394351|t=2020. Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19 |pdf=|usr=}}{{33394351}} gab.com Text Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19 JO: Virol Sin http://www.kidney.de/pget.php?&tw=1&pmid=33394351 #FOAvip Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most effective means to combat the pandemic. Here, we introduced the etiological and serological characteristics of COVID-19, discussed the current stage of development of human monoclonal antibodies against SARS-CoV-2 and summarized the antigenic epitopes in the S glycoprotein, which may deepen the understanding of the profile of immune recognition and response against SARS-CoV-2 and provide insight for the design of effective vaccines and antibody-based therapies. Twit Text FOAVip Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19 ????Virol Sin http://www.kidney.de/pget.php?&tw=1&pmid=33394351 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33394351 #FOAvip English Wikipedia <ref>{{Cite pmid|33394351}}</ref> Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19 #MMPMID33394351 Chen J; Huang R; Nie Y; Wen X; Wu Y Virol Sin 2020[Dec]; 35 (6): 713-724 PMID33394351show ga Coronavirus disease 2019 (COVID-19), reminiscent of the severe acute respiratory syndrome (SARS) outbreak in 2003, has been a tragic disaster to people all over the world. As there is no specific drug for COVID-19, neutralizing antibodies are attracting more and more attention as one of the most effective means to combat the pandemic. Here, we introduced the etiological and serological characteristics of COVID-19, discussed the current stage of development of human monoclonal antibodies against SARS-CoV-2 and summarized the antigenic epitopes in the S glycoprotein, which may deepen the understanding of the profile of immune recognition and response against SARS-CoV-2 and provide insight for the design of effective vaccines and antibody-based therapies. |*COVID-19 Drug Treatment[MESH] |Animals[MESH] |Antibodies, Monoclonal/immunology/*therapeutic use[MESH] |Antibodies, Neutralizing/immunology/*therapeutic use[MESH] |Antibodies, Viral/immunology[MESH] |Antigens, Viral/chemistry/immunology[MESH] |COVID-19/*immunology[MESH] |Epitopes/immunology[MESH] |Humans[MESH] |Neutralization Tests[MESH] |Pandemics[MESH] |SARS-CoV-2/*immunology[MESH]Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Agai(epmc).pdf DeepDyve Pubget Overpricing